Date: 10th October 2023 at 18:00 CET time
Speaker: Michael Neumaier (Mannheim, Germany ) - Dept of Clinical Chemistry, University of Heidelberg and Institute for Clinical Chemistry, Mannheim, Germany
Learning objectives:
1. the specificity of molecular changes in the development and progression of malignant disease
2. the use of cell-free nucleic acids in bodily fluids for early diagnosis of cancer
3. the use of ctDNA monitoring for testing tumor resistance to therapy and improved clinical decision-making.
4. can ctDNA be a reliable topological information?
Cilck here to register
